Logo of eidLink to Publisher's site
Emerg Infect Dis. 1996 Jul-Sep; 2(3): 192–199.
PMCID: PMC2626789

Coccidioidomycosis: a reemerging infectious disease.


Coccidioides immitis, the primary pathogenic fungus that causes coccidioidomycosis, is most commonly found in the deserts of the southwestern United States and Central and South America. During the early 1990s, the incidence of coccidioidomycosis in California increased dramatically. Even though most infections are subclinical or self-limited, the outbreak is estimated to have cost more than $66 million in direct medical expenses and time lost from work in Kern County, California, alone. In addition to the financial loss, this pathogen causes serious and life-threatening disseminated infections, especially among the immunosuppressed, including AIDS patients. This article discusses factors that may be responsible for the increased incidence of coccidioidomycosis (e.g., climatic and demographic changes and the clinical problems of coccidioidomycosis in the immunocompromised) and new approaches to therapy and prevention.

Full Text

The Full Text of this article is available as a PDF (683K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis. 1995 Jan-Mar;1(1):7–15. [PMC free article] [PubMed]
  • Harrison WR, Merbs CF, Leathers CR. Evidence of coccidioidomycosis in the skeleton of an ancient Arizona Indian. J Infect Dis. 1991 Aug;164(2):436–437. [PubMed]
  • Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol. 1988;2:199–238. [PubMed]
  • CONVERSE JL. Effect of surface active agents on endosporulation of Coccidioides immitis in a chemically defined medium. J Bacteriol. 1957 Jul;74(1):106–107. [PMC free article] [PubMed]
  • Kamel SM, Wheat LJ, Garten ML, Bartlett MS, Tansey MR, Tewari RP. Production and characterization of murine monoclonal antibodies to Histoplasma capsulatum yeast cell antigens. Infect Immun. 1989 Mar;57(3):896–901. [PMC free article] [PubMed]
  • Lacy GH, Swatek FE. Soil ecology of Coccidioides immitis at Amerindian middens in California. Appl Microbiol. 1974 Feb;27(2):379–388. [PMC free article] [PubMed]
  • MADDY KT. The geographic distribution of coccidioides immitis and possible ecologic implications. Ariz Med. 1958 Mar;15(3):178–188. [PubMed]
  • Pappagianis D, Einstein H. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West J Med. 1978 Dec;129(6):527–530. [PMC free article] [PubMed]
  • Coccidioidomycosis following the Northridge Earthquake--California, 1994. MMWR Morb Mortal Wkly Rep. 1994 Mar 18;43(10):194–195. [PubMed]
  • Johnson WM. Occupational factors in coccidioidomycosis. J Occup Med. 1981 May;23(5):367–374. [PubMed]
  • Werner SB, Pappagianis D. Coccidioidomycosis in Northern California. An outbreak among archeology students near Red Bluff. Calif Med. 1973 Sep;119(3):16–20. [PMC free article] [PubMed]
  • Galgiani JN. Coccidioidomycosis. West J Med. 1993 Aug;159(2):153–171. [PMC free article] [PubMed]
  • Smith CE. Epidemiology of Acute Coccidioidomycosis with Erythema Nodosum ("San Joaquin" or "Valley Fever"). Am J Public Health Nations Health. 1940 Jun;30(6):600–611. [PMC free article] [PubMed]
  • Baker EJ, Hawkins JA, Waskow EA. Surgery for coccidioidomycosis in 52 diabetic patients with special reference to related immunologic factors. J Thorac Cardiovasc Surg. 1978 May;75(5):680–687. [PubMed]
  • SMITH CE, BEARD RR, SAITO MT. Pathogenesis of coccidioidomycosis with special reference to pulmonary cavitation. Ann Intern Med. 1948 Oct;29(4):623–655. [PubMed]
  • Williams PL, Sable DL, Mendez P, Smyth LT. Symptomatic coccidioidomycosis following a severe natural dust storm. An outbreak at the Naval Air Station, Lemoore, Calif. Chest. 1979 Nov;76(5):566–570. [PubMed]
  • Kirkland TN, Fierer J. Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection. Infect Immun. 1983 Jun;40(3):912–916. [PMC free article] [PubMed]
  • Kirkland TN, Fierer J. Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. J Immunol. 1985 Jul;135(1):548–552. [PubMed]
  • Cox RA, Kennell W. Suppression of T-lymphocyte response by Coccidioides immitis antigen. Infect Immun. 1988 Jun;56(6):1424–1429. [PMC free article] [PubMed]
  • Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy. An analysis of ten cases among 47,120 pregnancies. Chest. 1988 Aug;94(2):376–379. [PubMed]
  • Powell BL, Drutz DJ, Huppert M, Sun SH. Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy. Infect Immun. 1983 May;40(2):478–485. [PMC free article] [PubMed]
  • Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993 Jul;14(7):353–356. [PubMed]
  • Beaman L, Pappagianis D, Benjamini E. Significance of T cells in resistance to experimental murine coccidioidomycosis. Infect Immun. 1977 Sep;17(3):580–585. [PMC free article] [PubMed]
  • Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis. 1993 Mar;16(3):349–354. [PubMed]
  • Update: coccidioidomycosis--California, 1991-1993. MMWR Morb Mortal Wkly Rep. 1994 Jun 17;43(23):421–423. [PubMed]
  • Dodge RR, Lebowitz MD, Barbee R, Burrows B. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health. 1985 Aug;75(8):863–865. [PMC free article] [PubMed]
  • Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med. 1982 Mar;142(3):489–494. [PubMed]
  • Rutala PJ, Smith JW. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci. 1978 May-Jun;275(3):283–295. [PubMed]
  • Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol. 1996 Jan 15;156(2):644–652. [PubMed]
  • Bronnimann DA, Adam RD, Galgiani JN, Habib MP, Petersen EA, Porter B, Bloom JW. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Mar;106(3):372–379. [PubMed]
  • Fish DG, Ampel NM, Galgiani JN, Dols CL, Kelly PC, Johnson CH, Pappagianis D, Edwards JE, Wasserman RB, Clark RJ, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990 Nov;69(6):384–391. [PubMed]
  • Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993 Mar;94(3):235–240. [PubMed]
  • Galgiani JN, Catanzaro A, Cloud GA, Higgs J, Friedman BA, Larsen RA, Graybill JR. Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med. 1993 Jul 1;119(1):28–35. [PubMed]
  • Tucker RM, Denning DW, Dupont B, Stevens DA. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med. 1990 Jan 15;112(2):108–112. [PubMed]
  • Dewsnup DH, Galgiani JN, Graybill JR, Diaz M, Rendon A, Cloud GA, Stevens DA. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996 Feb 1;124(3):305–310. [PubMed]
  • Catanzaro A, Fierer J, Friedman PJ. Fluconazole in the treatment of persistent coccidioidomycosis. Chest. 1990 Mar;97(3):666–669. [PubMed]
  • Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA. Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. Am J Med. 1990 Sep;89(3):282–290. [PubMed]
  • Catanzaro A, Galgiani JN, Levine BE, Sharkey-Mathis PK, Fierer J, Stevens DA, Chapman SW, Cloud G. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med. 1995 Mar;98(3):249–256. [PubMed]
  • LEVINE HB, COBB JM, SMITH CE. Immunogenicity of spherule-endospore vaccines of Coccidioides immitis for mice. J Immunol. 1961 Aug;87:218–227. [PubMed]
  • Pappagianis D. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Am Rev Respir Dis. 1993 Sep;148(3):656–660. [PubMed]
  • Huppert M, Spratt NS, Vukovich KR, Sun SH, Rice EH. Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis. Infect Immun. 1978 May;20(2):541–551. [PMC free article] [PubMed]
  • Cox RA, Britt LA. Isolation and identification of an exoantigen specific for Coccidioides immitis. Infect Immun. 1986 Apr;52(1):138–143. [PMC free article] [PubMed]
  • Cole GT, Kirkland TN, Sun SH. An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis. Infect Immun. 1987 Mar;55(3):657–667. [PMC free article] [PubMed]
  • Cole GT, Kirkland TN, Franco M, Zhu S, Yuan L, Sun SH, Hearn VM. Immunoreactivity of a surface wall fraction produced by spherules of Coccidioides immitis. Infect Immun. 1988 Oct;56(10):2695–2701. [PMC free article] [PubMed]
  • Dugger KO, Galgiani JN, Ampel NM, Sun SH, Magee DM, Harrison J, Law JH. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect Immun. 1991 Jul;59(7):2245–2251. [PMC free article] [PubMed]
  • Galgiani JN, Sun SH, Dugger KO, Ampel NM, Grace GG, Harrison J, Wieden MA. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination. Infect Immun. 1992 Jul;60(7):2627–2635. [PMC free article] [PubMed]
  • Kirkland TN, Zhu SW, Kruse D, Hsu LL, Seshan KR, Cole GT. Coccidioides immitis fractions which are antigenic for immune T lymphocytes. Infect Immun. 1991 Nov;59(11):3952–3961. [PMC free article] [PubMed]
  • Wyckoff EE, Pishko EJ, Kirkland TN, Cole GT. Cloning and expression of a gene encoding a T-cell reactive protein from Coccidioides immitis: homology to 4-hydroxyphenylpyruvate dioxygenase and the mammalian F antigen. Gene. 1995 Aug 8;161(1):107–111. [PubMed]
  • Lecara G, Cox RA, Simpson RB. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen. Infect Immun. 1983 Jan;39(1):473–475. [PMC free article] [PubMed]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...